Balthaser Kevin

CIK 00019575541 companyWAYNE, PA

SEC Profile

Transactions

Companies

Filings

CIK

0001957554

Recent Transactions

50 trades

Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2026-01-02−13,200→ 13,600 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2026-01-02+13,200→ 164,874 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2026-01-02$2.88/sh−4,461→ 160,413 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2026-01-01$3.01/sh−2,250→ 151,674 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2026-01-01−7,500→ 7,500 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2026-01-01+7,500→ 153,924 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2025-12-31+73,750→ 166,358 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2025-12-31$3.01/sh−19,934→ 146,424 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2025-12-31−73,750→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2025-03-01+2,375→ 93,335 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2025-03-01+1,100→ 90,960 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2025-03-01−2,375→ 2,375 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2025-03-01−1,100→ 0 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2025-03-01$1.99/sh−727→ 92,608 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2025-02-03+88,100→ 88,100 total
Award
Aclaris Therapeutics, Inc.$ACRS
Employee Stock Option (Right to Buy)
2025-02-03+308,200→ 308,200 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2025-02-01+14,750→ 95,676 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2025-02-01−14,750→ 44,250 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2025-02-01$2.48/sh−5,816→ 89,860 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2025-01-02$2.48/sh−5,059→ 80,926 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2025-01-02+40,000→ 40,000 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2025-01-02+13,200→ 85,985 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2025-01-02−13,200→ 26,800 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2025-01-01$2.48/sh−2,430→ 72,785 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2025-01-01+7,500→ 75,215 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2025-01-01−7,500→ 15,000 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2024-12-31−73,750→ 73,750 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-12-31+73,750→ 98,447 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-12-31$2.48/sh−30,732→ 67,715 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-09-01$1.18/sh−286→ 24,697 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-09-01+1,000→ 24,983 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2024-09-01−1,000→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-03-02+1,500→ 24,410 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-03-02$1.24/sh−427→ 23,983 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2024-03-02−1,500→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2024-03-01−2,375→ 4,750 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-03-01$1.24/sh−677→ 22,910 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-03-01+2,375→ 23,587 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-03-01$1.24/sh−313→ 21,212 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-03-01+1,100→ 21,525 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2024-03-01−1,100→ 1,100 total
Award
Aclaris Therapeutics, Inc.$ACRS
Employee Stock Option (Right to Buy)
2024-02-01+206,500→ 206,500 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2024-02-01+59,000→ 59,000 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2024-02-01+147,500→ 147,500 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-01-01+7,500→ 22,961 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-01-01$1.05/sh−2,536→ 20,425 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2024-01-01−7,500→ 22,500 total
Purchase
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2023-09-06$7.90/sh+9,490→ 15,461 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2023-09-01$7.90/sh−285→ 5,971 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2023-09-01+1,000→ 6,256 total

Companies

Aclaris Therapeutics, Inc.
Chief Financial Officer
$ACRS

Recent Filings

Address

C/O ACLARIS THERAPEUTICS, INC. 701 LEE ROAD, SUITE 103

WAYNE, PA, 19087

View on SEC.gov